Nemaura Medical Inc. (NASDAQ: NMRD) Diabetes, Obesity Solutions Differentiated in Form and Function
24. September 2021 08:30 ET
|
Nemaura Medical Inc.
NEW YORK, Sept. 24, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio -- Nemaura Medical Inc. (NASDAQ: NMRD) announces the availability of a broadcast titled, “Healthcare Technologies Spearheading Modern...
Nemaura Medical Inc. (NASDAQ: NMRD) Offers Sought-After Solutions in Areas of Unmet Medical Need
22. September 2021 08:30 ET
|
Nemaura Medical Inc.
NEW YORK, Sept. 22, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Nemaura Medical Inc. (NASDAQ: NMRD) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+...
Nemaura Medical Appoints Jay L. Warner as Head of U.S. Commercial Operations
01. Februar 2021 08:00 ET
|
Nemaura Medical Inc.
LOUGHBOROUGH, England, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical To Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference
11. Januar 2021 08:00 ET
|
Nemaura Medical Inc.
LOUGHBOROUGH, England, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Launches BEAT®diabetes Program and Its Novel proBEAT™ Non-Invasive, Daily-Wear Adhesive Glucose Monitor
17. Dezember 2020 08:00 ET
|
Nemaura Medical Inc.
LOUGHBOROUGH, England, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical to Present at the 13th Annual LD Micro Main Event Virtual Conference
11. Dezember 2020 09:00 ET
|
Nemaura Medical Inc.
LOUGHBOROUGH, England, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Launches BEAT™diabetes Program Through New Web Presence and Re-Launches Enhanced Corporate Website
17. November 2020 08:00 ET
|
Nemaura Medical Inc.
LOUGHBOROUGH, England, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Reports Financial Results for Second Quarter of Fiscal Year 2020/21 and Provides Corporate Update
16. November 2020 08:00 ET
|
Nemaura Medical Inc.
LOUGHBOROUGH, England, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical to Present at Virtual Diabetes Technology Meeting 2020
22. Oktober 2020 08:00 ET
|
Nemaura Medical Inc.
LOUGHBOROUGH, England, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Licenses Validated Mobile Application to Create Powerful Diabetes Prevention and Management Suite of Products
21. September 2020 08:00 ET
|
Nemaura Medical Inc.
Clinically proven app from Healthimation, LLC, to be paired with Company’s proBEAT™ non-invasive CGM system solution to offer convenient and effective management of pre-diabetes and Type 2 diabetes ...